Trialjectory Boasts Over 54 Percent Growth in New Cancer Patient Users from Diverse Ethnic and Racial Backgrounds in Q1 2022
/PRNewswire/ -- Trialjectory, the AI-powered decision-support platform for patients, healthcare providers and pharmaceutical companies, announced today that it...
Tzvia Bader Fast Company Company Committed To Including Patients Drug Administration Company Committed Including Patients
Source: prnewswire.com